2026-08-10 — Copenhagen-based Novonesis agreed to buy out the remaining shares of Australian yeast biotech MicroBioGen to strengthen its yeast R&D capabilities.
Copenhagen-based Novonesis agreed to acquire the remaining shares of Australian yeast biotech MicroBioGen, in which it has held a 23% stake since 2013, to strengthen yeast R&D capabilities for industrial applications including bioethanol.
Terms of the deal were not disclosed, and completion requires regulatory clearances including from Australia's ACCC. The two companies previously co-developed the Innova yeast series.
Copenhagen-based Novonesis agreed to buy out the remaining shares of Australian yeast biotech MicroBioGen to strengthen its yeast R&D capabilities.
· Biologicals · Denmark / Australia · 2 min
Copenhagen-based Novonesis agreed to acquire the remaining shares of Australian yeast biotech MicroBioGen, in which it has held a 23% stake since 2013, to strengthen yeast R&D capabilities for industrial applications including bioethanol.
Terms of the deal were not disclosed, and completion requires regulatory clearances including from Australia's ACCC. The two companies previously co-developed the Innova yeast series.
Source: BioSpace